New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase
申请人:PFIZER INC.
公开号:EP0609960A1
公开(公告)日:1994-08-10
Compounds of the formula
the pharmaceutically acceptable salts thereof, wherein Q is a substituted pyridine or pyrimidine group and R¹ incorporates a hydrocarbon group of from 4 to 16 carbon atoms, are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
式中的化合物
其中 Q 是取代的吡啶或嘧啶基团,R¹ 包含 4 至 16 个碳原子的烃基,是酰基辅酶 A:胆固醇酰基转移酶(ACAT)的抑制剂,可用作降血脂药和抗动脉粥样硬化药。